Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting
Benedetta Chiusole(Istituto Oncologico Veneto), Antonella Brunello(Istituto Oncologico Veneto), Giuseppe Sergi(University of Padua), Giuseppina Tierno(Istituto Oncologico Veneto), Fabio Murtas(University of Padua), Eleonora Bergo(University of Insubria), A. Banzato(Istituto Oncologico Veneto), Marta Sbaraglia(University of Padua), Marco Rastrelli(Istituti di Ricovero e Cura a Carattere Scientifico), Selma Ahcene Djaballah(Istituto Oncologico Veneto), Maura Gatti(Istituto Oncologico Veneto), Antonella Galiano(Istituto Oncologico Veneto), Ilaria Tortorelli(Istituto Oncologico Veneto), Antonio Di Maggio(Istituto Oncologico Veneto), Vittorina Zagonel(Istituto Oncologico Veneto)
Cited by 5
Related Papers
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
|Modern Pathology|2015|317